Whitepapers/App Notes/Posters

Application note: Pharmaceutical analysis using UV-Vis: compliance with USP Chapter <857> and European pharmacopoeia (Ph. Eur. Chapter 2.2.25)

Posted: 25 June 2020 | | No comments yet

USP general chapter <857> and Ph. Eur. chapter 2.2.25 guide instrument operational qualification protocols for UV-Vis spectroscopy. This technical note demonstrates how to ensure qualification as per global pharmacopoeias’ requirements.

UV-Vis spectroscopy is a widely used analytical technique in quality assurance/ quality control (QA/QC) and pharmaceutical research. It is critical that any laboratory in such environments set up appropriate controls for laboratory access and ensure that good manufacturing practice (GMP) documentation, including system suitability tests (SSTs) and standard operating procedures (SOPs) are available and followed. The United States pharmacopoeia (USP) and the European pharmacopoeia (Ph. Eur.) guidelines describe how to verify that the analytical performance of UV-Vis spectrophotometers is suitable for the intended operational range of the analysis. 











    To read this application note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


    *

    *

    *

    *

    *

    *

    *

    *

    Would you like to learn more about Agilent Cary 3500?

    YesNo

     

    YES, I would like to receive email updates about Agilent products, services and events. For full details of how we will treat your information please view our privacy policy: www.agilent.com/home/privacy-policy

    This content is provided to you for free thanks to the kind support of our sponsor: Agilent

    Send this to a friend